Skip to main content

Familial Cancer

Ausgabe 1/2015

Inhalt (23 Artikel)

Original Article

Single nucleotide polymorphisms in PDCD6 gene are associated with the development of cervical squamous cell carcinoma

Bin Zhou, Peng Bai, Hui Xue, Zhu Zhang, Shaoqing Shi, Kui Zhang, Yanyun Wang, Kana Wang, Yi Quan, Yaping Song, Lin Zhang

Original Article

Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing

Yanfang Guan, Hong Hu, Yin Peng, Yuhua Gong, Yuting Yi, Libin Shao, Tengfei Liu, Gairui Li, Rongjiao Wang, Pingping Dai, Yves-Jean Bignon, Zhe Xiao, Ling Yang, Feng Mu, Liang Xiao, Zeming Xie, Wenhui Yan, Nan Xu, Dongxian Zhou, Xin Yi

Review

Mitochondrial membrane potential and reactive oxygen species in cancer stem cells

Bei-bei Zhang, Dao-gang Wang, Fen-fen Guo, Chao Xuan

Original Article

Desmoid tumour in familial adenomatous polyposis patients: responses to treatments

Thibault Desurmont, Jérémie H. Lefèvre, Conor Shields, Chrystelle Colas, Emmanuel Tiret, Yann Parc

Original Article

APC rearrangements in familial adenomatous polyposis: heterogeneity of deletion lengths and breakpoint sequences underlies similar phenotypes

Marialuisa Quadri, Annalisa Vetro, Viviana Gismondi, Monica Marabelli, Lucio Bertario, Paola Sala, Liliana Varesco, Orsetta Zuffardi, Guglielmina N. Ranzani

Short Communication

Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case

Jinru Shia, Zsofia K. Stadler, Martin R. Weiser, Efsevia Vakiani, Robin Mendelsohn, Arnold J. Markowitz, Moshe Shike, C. Richard Boland, David S. Klimstra

Original Article

Identification of a novel MSH6 germline variant in a family with multiple gastro-intestinal malignancies by next generation sequencing

Ashton A. Connor, Hagit Katzov-Eckert, Thomas Whelan, Melyssa Aronson, Lynette Lau, Christian Marshall, George S. Charames, Aaron Pollett, Steven Gallinger, Jordan Lerner-Ellis

Short Communication

MLH1 promotor hypermethylation does not rule out a diagnosis of Lynch syndrome: a case report

Victoria M. Raymond, Arden M. Morris, Khaled S. Hafez, Joel K. Greenson

Open Access Original Article

Gly322Asp and Asn127Ser single nucleotide polymorphisms (SNPs) of hMSH2 mismatch repair gene and the risk of triple-negative breast cancer in Polish women

Beata Smolarz, Marianna Makowska, Dariusz Samulak, Magdalena M. Michalska, Hanna Romanowicz

Short Communication

Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation

Ingrid P. Vogelaar, Rachel S. van der Post, Esther van de Vosse, J. Han J. M. van Krieken, Nicoline Hoogerbrugge, Marjolijn J. L. Ligtenberg, Encarna Gómez García

Original Article

Familial and sporadic pancreatic cancer share the same molecular pathogenesis

Alexis L. Norris, Nicholas J. Roberts, Siân Jones, Sarah J. Wheelan, Nickolas Papadopoulos, Bert Vogelstein, Kenneth W. Kinzler, Ralph H. Hruban, Alison P. Klein, James R. Eshleman

Original Article

Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer

Louise Heiniger, Phyllis N. Butow, Joseph Coll, Tracey Bullen, Judy Wilson, Brandi Baylock, Bettina Meiser, Melanie A. Price

Original Article

Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability

Jacopo Berrino, Franco Berrino, Silvia Francisci, Bernard Peissel, Jacopo Azzollini, Valeria Pensotti, Paolo Radice, Patrizia Pasanisi, Siranoush Manoukian

Original Article

Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations

Lise B. Ahlborn, Ane Y. Steffensen, Lars Jønson, Malene Djursby, Finn C. Nielsen, Anne-Marie Gerdes, Thomas V. O. Hansen

Open Access Original Article

Population-based genetic risk prediction and stratification for ovarian cancer: views from women at high risk

Belinda Rahman, Susanne F. Meisel, Lindsay Fraser, Lucy Side, Sue Gessler, Jane Wardle, Anne Lanceley

Short Communication

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe

Natalia Bogdanova, Alexandr V. Togo, Magdalena Ratajska, Wojtek Kluźniak, Zalina Takhirova, Theresa Tarp, Darya Prokofyeva, Marina Bermisheva, Grigoriy A. Yanus, Tatiana V. Gorodnova, Anna P. Sokolenko, Alina Kuźniacka, Amira Podolak, Maciej Stukan, Dominika Wokołorczyk, Jacek Gronwald, Danuta Vasilevska, Vilius Rudaitis, Ingo B. Runnebaum, Matthias Dürst, Tjoung-Won Park-Simon, Peter Hillemanns, Natalia Antonenkova, Elza Khusnutdinova, Janusz Limon, Jan Lubinski, Cezary Cybulski, Evgeny Imyanitov, Thilo Dörk

Short Communication

Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome

Kirsty Mann, Jill Magee, Marine Guillaud-Bataille, Christophe Blondel, Brigitte Bressac-de Paillerets, Josie Yeatman, Ingrid Winship

Original Article

Vestibular schwannoma in a patient with neurofibromatosis type 1: clinical report and literature review

Aamira Huq, Maira Kentwell, Amanda Tirimacco, Jacqueline Rossini, Lesley Rawlings, Ingrid Winship

Original Article

Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li–Fraumeni syndrome

Anna Etzold, Julia C. Schröder, Oliver Bartsch, Ulrich Zechner, Danuta Galetzka

Original Article

Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals

Shanna L. Gustafson, Victoria M. Raymond, Monica L. Marvin, Tobias Else, Erika Koeppe, Elena M. Stoffel, Jessica N. Everett

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.